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Several ﬁeld and laboratory studies have shown
induction of adverse effects in wildlife species
and populations upon exposure to endocrine-
disrupting chemicals (EDCs). These effects
vary from subtle changes in the physiology and
sexual behavior of species to permanently
altered sexual differentiation (Vos et al. 2000).
The vast majority of endocrine disruption
research in ﬁsh has focused on estrogenic xeno-
biotics. This work has used the egg yolk pro-
tein precursor, vitellogenin (VTG), as an
unambiguous biomarker for estrogens in a
variety of model species (Allen et al. 1999;
Denslow et al. 1999; Folmar et al. 1996;
Heppell et al. 1995; Purdom et al. 1994;
Sumpter and Jobling 1995).
The role of environmental androgens and
antiandrogens has until recently been over-
looked, most likely because of the lack of a
sensitive in vivo system for the detection of
such activity.
Nevertheless, the only androgenic indus-
trial effluent identified to date is pulp mill
efﬂuent. Several reports have focused on the
masculinizing effect of pulp mill effluent on
female mosquitofish (Cody and Bortone
1997; Howell and Denton 1989; Parks et al.
2001), male-biased eelpout embryos (Larsson
et al. 2000), and induction of spiggin in
female sticklebacks (Katsiadaki et al. 2002b).
Although domestic effluent is suspected to
have a high content of natural androgens,
an advanced level of treatment, such as
percolating filter beds and activated sludge
systems, seems to be very efﬁcient in removing
the responsible agents (Thomas et al. 2002).
More recently, concerns were expressed
that trenbolone acetate, a growth promoter
used in livestock, is a strong androgen agonist
(Ankley et al. 2003; Wilson et al. 2002).
Although androgens do not appear to be
as widespread as estrogens in the environ-
ment, a nationwide survey of endocrine activ-
ity of ﬁnal sewage efﬂuents across the United
Kingdom, using the yeast androgen screen
assay, has revealed signiﬁcant antiandrogenic
activity (Environment Agency, in press).
Antiandrogens in general exert their effects
by occupying the androgen receptor (AR)
without activating it. Activation of the AR is
induced by ligand binding through conforma-
tional changes that lead to speciﬁc gene expres-
sion. Antiandrogens compete with androgens
for AR occupancy and subsequently block
receptor action. Two classes of antiandrogens
are currently recognized: steroidal derivatives,
which possess mixed agonistic and antagonistic
androgenic activity, and nonsteroidal deriva-
tives or “pure” antiandrogens, exempliﬁed by
flutamide, (2-methyl-N-[4-nitro-3-(tri-
flouromethyl)phenyl]propanamide).
Flutamide (FL) and its derivatives are the
main representatives of the latter category, and
they have been studied extensively because of
their proven clinical efﬁcacy in the treatment
of prostate cancer (Singh et al. 2000). They are
potent AR antagonists that compete with
androgens for binding to the AR and prevent
AR DNA binding and transcription of andro-
gen-dependent genes. 
Several environmental chemicals have been
shown to compete with androgens at a recep-
tor level. Kelce et al. (1994) and Gray et al.
(1994) identified the first environmental
antiandrogens that share the same mechanism
of endocrine disruption with FL, as M1 and
M2 metabolites of the fungicide vinclozolin.
Vinclozolin (VZ) itself has poor afﬁnity for the
mammalian AR (Kelce et al. 1994). However,
in vivo, VZ is hydrolyzed to two open-ringed
metabolites, M1 (2-[[(3,5-dichlorophenyl)-
carbamoyl]oxy]-2-methyl-3-butenoic acid) and
M2 (3´, 5´-dichloro-2-hydroxy-2-methylbut-
3-enanilide), which act as AR antagonists
by preventing transcription of androgen-
dependent genes (Wong et al. 1995).
The same mechanism of antiandrogenic
action was identiﬁed in p,p´-DDE (dichloro-
diphenyldichloroethylene), a persistent
metabolite of the pesticide DDT (dichloro-
diphenyltrichloroethane) that, as in the case of
VZ, prevents gene transcription in mammals
by binding to the AR (Kelce et al. 1995).
The fungicide procymidon alters sexual
differentiation in the male rat by also acting as
an AR antagonist both in vitro and in vivo
(Ostby et al. 1999; Vinggaard et al. 1999).
Linuron (LN), an herbicide applied to sup-
press broadleaf and grassy weeds, is a weak
competitive AR antagonist in vitro, induces a
positive response in the immature and adult rat
Hershberger assay, and suppresses androgen-
dependent gene expression (Cook et al. 1993;
Lambright et al. 2000; McIntyre et al. 2000).
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We have previously shown that exposure to exogenous androgens causes female sticklebacks
(Gasterosteus aculeatus) to produce the glue protein, spiggin, in their kidneys. This protein can be
quantiﬁed by an enzyme-linked immunosorbent assay developed and validated at the Centre for
Environment, Fisheries and Aquaculture Science. Here we report the development of an in vivo test
for the detection of environmental antiandrogens. The system involves the simultaneous exposure
of female sticklebacks to 17α-methyltestosterone (a model androgen) at 500 ng/L and suspected
environmental antiandrogens over a period of 21 days. The spiggin content of the kidneys is then
measured, and any antiandrogenic activity is evaluated by comparing the spiggin levels of female
ﬁsh exposed to antiandrogens to those of female ﬁsh exposed solely to the model androgen. The
assay detects the antiandrogenic activity of ﬂutamide, vinclozolin (both used at 250 µg/L), linuron
(at 150 µg/L), and fenitrothion (at 15 and 150 µg/L). These results provide the ﬁrst evidence of
in vivo antiandrogenic activity of both linuron and fenitrothion in teleosts. Although there are
other suggested ﬁsh species that could be used for this purpose, the stickleback is the only widely
available species in which it is now possible to study both estrogenic and antiandrogenic end points
in the same individual. Furthermore, the species is endemic and ubiquitous in Europe, and it pos-
sesses many ecological traits that make it better suited than other potential species for ﬁeld research
into endocrine disruption. Key words: antiandrogens, endocrine disruption, fenitrothion, ﬂutamide,
linuron, spiggin, stickleback, vinclozolin. Environ Health Perspect 114(suppl 1):115–121 (2006).
doi:10.1289/ehp.8063 available via http://dx.doi.org/ [Online 21 October 2005]Tamura et al. (2001) were ﬁrst to demon-
strate both in vitro and in vivo (rats,
Hershberger test) the antiandrogenicity of fen-
itrothion (O,O-dimethyl-O-4-nitro-m-tolyl
phosphorothioate), a widely used organophos-
phate pesticide. However, Sohoni et al. (2001)
observed no conclusive antiandrogenic effects
of fenitrothion (FN) in either intact or cas-
trated male rats. In addition, Turner et al.
(2002) failed to demonstrate signiﬁcant alter-
ation of androgen-dependent sexual differenti-
ation in male rats exposed in utero, and they
concluded that FN is only weakly antiandro-
genic. Nevertheless, several other reports con-
ﬁrmed an androgen antagonism in vitro using
a number of different systems (Freyberger and
Ahr, 2004; Sohoni et al. 2001).
Antiandrogens may disrupt male sexual
differentiation and performance by interfering
with androgen signaling at levels other than the
AR, such as androgen production, transport,
and metabolism.
Inhibitors of the enzyme 5α-reductase
(responsible for the conversion of testosterone
in the more potent dihydrotestosterone in
mammals), such as finasteride, provide
another example of an antiandrogen that pro-
duces effects on androgen-regulated sexual
differentiation by a mechanism that does not
involve AR but, rather, causes interference
with androgen production.
Administration of di-(n-butyl) phthalate
during late gestation in rats also disrupts
androgen-regulated male reproductive develop-
ment (Mylchreest et al. 1999). Di-(n-butyl)
phthalate and its metabolites do not show any
afﬁnity for the AR in vitro; thus, the mecha-
nism of action is not by AR interaction.
Interestingly, fetal exposure to high doses
of estrogens can produce cryptorchidism and
hypospadias (Newbold 1995). In vitro studies
have also confirmed the affinity of natural
estrogens (Sohoni and Sumpter 1998) or
environmental estrogens (Lee et al. 2003) for
the AR. However, estrogens can also have
antiandrogenic effects by acting on feedback
mechanisms (inhibition of luteinizing hor-
mone and follicle-stimulating hormone) and
by preventing secretion of testosterone from
the testes. Other researchers support the view
that neonatal treatment of rats with xenoe-
strogens induces reproductive abnormalities
by disturbing the androgen/estrogen balance
(Rivas et al. 2002).
Regardless of the mechanism through
which a xenobiotic interferes with the
endocrine system, its signiﬁcance depends on
the timing of exposure. Indeed, when adult
individuals are exposed to EDCs, the effects
are reversible once the exposure ceases. In
contrast, the consequences of exposure during
organogenesis may result in irreversible
deleterious developmental effects such as
those observed after in ovo exposure to the
pesticide DDT in birds (Fry 1995) and those
observed after in utero exposure to diethyl-
stilbestrol in rodents and humans (Herbst and
Anderson 1990; Newbold et al. 1990).
The importance of the issue is highlighted
by a large number of studies undertaken to
link human adverse effects and exposure to
EDCs in the last decade. Evidence for the
effect of EDCs in human health includes the
increased incidence of idiopathic hypospadias,
alterations of the male genitalia, pseudo-
hermaphroditism, decline in sperm counts,
and the increasing incidence of breast cancer
among females and testicular and prostate
cancers among males (Kelce and Wilson
1997; Topari et al. 1996).
The only robust assay for antiandrogens
thus far has been that described by Hershberger
et al. (1953). The basis of the assay is that cas-
trated sexually mature male rats undergo
regression of androgen-sensitive tissues (testes,
prostate, epididymis, seminal vesicle, and lev-
ator ani muscles). These tissues are restored to
their original weight upon treatment with
testosterone, and that growth can be blocked
by the concomitant administration of an
antiandrogen.
In view of the numerous clinical implica-
tions in human health and that the only reli-
able antiandrogen bioassay requires castrated
rats, a simple in vivo test using intact ﬁsh to
screen and identify environmental antiandro-
gens is very important and desirable. The pur-
pose of this study was to test the possibility of
adapting the stickleback androgen bioassay,
based on spiggin production (Katsiadaki et al.
2002a), for the detection of environmental
antiandrogens and to perform a preliminary
screen for the antiandrogenic activity of
selected environmental contaminants.
Materials and Methods
Chemicals, consumables, and equipment.
Dihydrotestosterone (DHT), 17α-methyl-
testosterone (17α-MT), FL, and ethinyl-estra-
diol (EE2) were obtained from Sigma-Aldrich
Co. Ltd. (Dorset, UK). VZ, LN, and FN were
purchased from QMX Laboratories Ltd
(Thaxted, Essex, UK).
Fish. Wild three-spined sticklebacks were
obtained with hand nets from U.K. rivers in the
Kent and Reading areas when they were only a
few weeks old, and they were kept in the labo-
ratory for 6 months before the experiments.
Stock population. The fish were kept in
brackish water at 12°C with a photoperiod of
8:16 hr light:dark, a regimen in which the ﬁsh
will remain reproductively quiescent. Only ﬁsh
that had been kept under these conditions, that
weighed > 0.8 µg, and had no external signs of
parasitism were used for the experiments.
Experimental populations. Fish (groups of
25 to 30) were transferred to 40-L glass aquaria
containing fresh water. The photoperiod was
12:12 hr light:dark, and the temperature was
15°C. Both photoperiod and temperature for
the experimental ﬁsh were chosen on the basis
that these conditions were neither stimulatory
nor inhibitory for the reproductive system.
Tanks were aerated constantly. Daily readings
from each tank were taken for temperature,
dissolved oxygen, pH, and conductivity. The
ﬁsh were fed every other day throughout the
exposure period with a combination of frozen
shrimp, artemia, and bloodworm.
Laboratory exposure to androgens/anti-
androgens. The test system we used to assess
antiandrogenic activity used female stickle-
backs that were simultaneously treated with a
model androgen. However, as stickleback sex-
ing outside the breeding season is a difficult
task, some males were present in the tanks.
Semistatic exposure. For this experiment,
we used the synthetic model androgen
17α-MT at 5 and 0.5 µg/L to induce the glue
protein spiggin. We chose the semistatic sys-
tem for administration of the test compounds
because of the large volumes of pesticides
needed for a ﬂow-through exposure. For this
process, two-thirds of the aquarium water was
removed every 48 hr and replaced with fresh
water plus a fresh dose of compound. Previous
exposures to 17α-MT have indicated that the
androgen is stable in water over a period of
48 hr and appropriate to use for semistatic
exposures during screening of xenobiotics
(Katsiadaki et al. 2002a). The environmental
antiandrogens were simultaneously adminis-
tered via the water, using the same semistatic
system. The highest concentrations tested were
either 250 or 150 µg/L and were based on toxi-
city data in fish. FL, VZ, LN, and FN were
screened for potential antiandrogenic activity.
Both suspected antiandrogens and
17α-MT were dissolved in methanol and
applied via the water as described above.
Appropriate volumes of vehicle solvents were
added to the controls. All treatments were
duplicated. The ﬁsh were exposed to the test
compounds for 3 weeks. Water samples were
taken each week before and immediately after
the addition of fresh solutions for the analytical
veriﬁcation of the tested chemicals.
Flow-through. We used a continuous
ﬂow-through system for exposure to DHT (a
nonaromatizable model androgen) at 5 µg/L
and various concentrations of FL (to construct
a dose–response curve). The flow rate was
100 mL/min. Previous unpublished data have
indicated that DHT has a low stability in
water, so it was not appropriate to use in semi-
static exposure. Verification of the test com-
pound concentration took place twice a week
over the 3-week period.
Spiggin measurements. At the end of the
exposure period, all fish were sacrificed by
destruction of the brain and then snap frozen
in liquid nitrogen. The ﬁsh were weighed to
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dissected out, placed in individual vials, and
labeled. The addition of 200 µL of a strong
denaturing buffer [100 mM Tris–HCl,
10 mM EDTA, 8 M urea, 2% SDS (wt/vol),
and 200 mM β-mercaptoethanol; pH 8.5]
and heating of the kidneys at 70°C for 30 min
followed. The enzyme-linked immunosorbent
assay (ELISA) procedure for spiggin has been
described in detail elsewhere (Katsiadaki et al.
2002a).
Histological analysis. In one experiment,
the kidney was divided into two equal parts,
one of which was used for the ELISA and the
other for histological examination. We have
previously described in detail the standard his-
tological protocols used for light microscopy
(Katsiadaki et al. 2002a).
Analytical verification of test concentra-
tions. We used solvents that were all HPLC
grade. Before extraction, a known amount of
diuron was added to each tank water sample
as an internal (surrogate or recovery) stan-
dard. Analytes were extracted from the sam-
ples using conditioned C18 solid phase
extraction (SPE) cartridges (Waters Ltd.,
Watford, UK). Water samples (1-L) were
pumped through a prefilter (0.45-µm pore
size; Pall Life Sciences, Portsmouth,
Hampshire, UK) before passing through the
SPE cartridge. After elution with methanol
and hexane, the ﬁnal extracts were reduced to
near-dryness and prepared in methanol.
The separation and detection of LN, FL
(including 2-hydroxyflutamide), and VZ
(including metabolites M1 and M2) were per-
formed by a HP1050 liquid chromatograph
(Agilent Technologies Ltd., Wokingham,
Berkshire, UK) coupled to a Platform II mass
spectrometer (Micromass, Altrincham,
Cheshire, UK). Analysis was conducted in the
negative ionization mode, using an electro-
spray interface. For FN, an atmospheric pres-
sure chemical ionization interface was used,
and detection was performed in the positive
mode. An acetonitrile:water gradient was
applied, and separation was achieved by using
either phenyl-hexyl or C8 minibore analytical
columns (Phenomenex, Torrance, CA, USA).
Selective ion monitoring (SIM) was then per-
formed in time-scheduled events. 
Quantification of LN, FL, and VZ was
achieved internally and relative to diuron;
hydroxyﬂutamide was determined relative to
the response of FL. Concentration data for FN
were derived from external calibration curves.
A competitive ELISA and a radioimmuno-
assay were used to measure 17α-MT and
DHT in water samples, respectively. We used
commercially available antibodies as described
previously (Katsiadaki et al. 2002a).
Statistical analysis. Differences between
groups were analyzed by analysis of variance
with a post-hoc Duncan’s test. Spiggin unit
data were logarithmically transformed before
analysis. Male and female ﬁsh were analyzed
separately because of the large differences in
spiggin contents between the sexes, particu-
larly in control groups.
Results
In vivo tests. During the early experiments, the
amounts of FL added to the aquaria were
500 µg/L of ambient water (Figures 1, 2). Both
the histological analysis of kidney epithelium
height (Figure 3) and the immunoassay devel-
oped for spiggin demonstrated that FL is highly
effective at inhibiting or reducing (depending
on the androgen dose used) spiggin induction
in androgen-treated sticklebacks or in photo-
periodically stimulated male sticklebacks.
These early results suggested that the
antiandrogenic effect of FL at a given dose
depends on the ligand’s concentration, its
binding afﬁnity for the AR in the stickleback
kidney, and on the presence of competing nat-
ural ligands (in the case of male fish). The
antagonizing effect is not observed when large
doses of androgens are used (i.e., 17α-MT at
500 µg/L, results not shown), is moderate at
1 µg/L 17α-MT, and is complete at 100 ng/L
17α-MT. The inhibitory effect of FL with the
simultaneous administration of 17α-MT at
100 ng/L is evident in male ﬁsh only because
17α-MT at this concentration did not show
much induction of spiggin in females (Figure 1).
Remarkably, inhibition of natural spiggin
production in photoperiodically stimulated
male sticklebacks was complete (Figure 2). It
should be noted that in males, the magnitude
of response to a temperature/photoperiod stim-
ulus is dependent on the time of the year that
the experiment is taking place. Generally, the
response increases from January to April, where
a maximum response is observed, remains high
until August, and then decreases during
November and December. The spiggin levels of
control ﬁsh in November are statistically lower
than those of the light-stimulated ﬁsh, whereas
this difference was not observed in the control
ﬁsh during February and April (Figure 2). This
observation is in line with previous studies that
have shown that extraretinal photoreception
and strong circadian rhythms are operating in
the male sticklebacks (Borg 1982; Bornestaf
and Borg 2000). Social hierarchies also inﬂu-
ence the magnitude of secondary sexual charac-
ters such as kidney hypertrophy, and therefore,
a sound knowledge of stickleback reproductive
biology is needed for the design of successful
experiments using male ﬁsh. Although it is pos-
sible that the time of the year and the reproduc-
tive status of the female ﬁsh might inﬂuence the
magnitude of response to androgen treatment,
more data are needed to establish this effect.
The inhibitory effect of FL on the
androgen-induced kidney hypertrophy in the
stickleback was confirmed histologically
(Figure 3).
Stickleback antiandrogen assay
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Figure 1. Amounts of spiggin per gram of body
weight (BW; ± SE) in female and male sticklebacks
exposed for 3 weeks to 17α-MT with or without
ﬂutamide.
*Significant (p < 0.05) inhibition of spiggin induction by
flutamide. #Significant (p < 0.05) reduction in spiggin pro-
duction by ﬂutamide.
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Figure 2. Amounts of spiggin per gram of body
weight (± SE) in male sticklebacks (controls and
photoperiodically stimulated with or without
ﬂutamide). 
*Signiﬁcant (p < 0.05) inhibition of natural spiggin induction
by ﬂutamide in comparison to light-stimulated male ﬁsh.
A B
Figure 3. Kidney sections of female sticklebacks treated with 17α-MT (10 µg/L) alone (A), and with 17α-MT
(10 µg/L) plus flutamide at 500 µg/L (B). Sections were stained with periodic acid–Schiff. Both micro-
photographs were taken under the same magniﬁcation. Scale bar = 50 µm. (A) Kidney epithelium height,
28.5 µm; (B) kidney epithelium height, 20.01 µm.We followed this interesting finding by
selecting two environmental antiandrogens,
namely, VZ at 250 and 25 µg/L and LN at
150 and 15 µg/L for screening. In addition, we
tested FL at 250 and 25 µg/L as a positive con-
trol. Because of the large volumes of environ-
mental antiandrogens used (i.e., 150–250
µg/L), it was decided that at least the prelimi-
nary screening test should be run in a semi-
static manner. We have previously reported
inhibition of DHT-induced (at 5 µg/L) kidney
hypertrophy in female ﬁsh by FL at 500 µg/L
(Katsiadaki et al. 2002b). We therefore chose
the same concentration for 17α-MT for the
screening of suspected environmental anti-
androgens. The results are presented in
Figure 4.
No inhibition of spiggin production was
apparent even by FL at 250 µg/L when female
fish were exposed to 5 µg/L 17α-MT
(Figure 4). Although we failed to demonstrate
antagonism by the test compounds, our results
provided further evidence that 17α-MT
strongly induces spiggin, as reported earlier
(Katsiadaki et al. 2002a). However, in the fol-
lowup experiment where 17α-MT was used at
0.5 µg/L, the conclusions are different. This
study included the organophosphate pesticide
FN at concentrations of 150 and 15 µg/L
(Figure 5).
All tested antiandrogens inhibited or sig-
nificantly reduced spiggin production by
androgen-treated female fish. In particular,
the inhibitory effects of FN are very impres-
sive, implying an even higher antiandrogenic
potency than the model FL.
When concerns were expressed that
17α-MT, which is aromatizable to an estro-
gen, was not an ideal androgen model, we
decided to replace it with DHT, which can-
not be converted to an estrogen. We therefore
designed another semistatic system of expo-
sure using DHT as a model androgen at
5 µg/L. We tested LN at 150 µg/L, procymi-
don at 150 µg/L, VZ at 250 µg/L, and
p,p´-DDE at 250 µg/L. These results are not
presented because only 20% of the female ﬁsh
in the androgen control group were spiggin
positive, thereby precluding any assessment
on inhibition. Chemical analysis of DHT in
the aquaria water conﬁrmed the lack of DHT
at the nominal concentration, thus suggesting
that this model androgen is very unstable
in water.
To conﬁrm this observation we designed
another flow-through test using DHT alone
at 5 µg/L (positive control), DHT along with
FL at 500 µg/L, and EE2 at 20 ng/L (negative
control).
We were able to reproduce our previous
data using the ﬂow-through system (Figure 6).
FL antagonized DHT more successfully than
17α-MT because the inhibition was complete
at 5 µg/L DHT, thereby imposing a higher
androgenic potency of 17α-MT over DHT,
which was also indicated through the levels of
spiggin units induced by the androgens alone.
In addition, it appears that EE2 might have an
antiandrogenic effect itself because there were
no males in breeding condition in this group
(Figure 6).
The next step involved in adapting the
spiggin bioassay for antiandrogens was to
obtain a dose–response curve for FL-induced
inhibition of spiggin production. Indeed, all
flow-through experiments up to this point
used FL 500 µg/L at a single concentration
only. The results of this study indicated that
FL successfully antagonized DHT at much
lower concentrations than 500 µg/L (Figure 7).
The very smooth standard curve conﬁrmed
the suitability of the stickleback bioassay as a
test for antiandrogens. Inhibition of DHT-
induced spiggin production in females
was complete at 125 µg/L FL and above and
was signiﬁcant at 10 µg/L. For the male ﬁsh,
total inhibition was observed at 250 µg/L of
FL, and significant reduction was noted at
50 µg/L.
Analytical verification of test concentra-
tions. Table 1 presents the recoveries of test
compounds in aquaria water. Analysis of
methanol washings from the interior walls of
the sample collection bottles as well as the
pre-SPE ﬁlters indicated negligible (< 0.5 µg/L)
concentrations per analyte. The recoveries of
diuron from the extracts ranged between 80
and 93% in all preparations.
Discussion
The present study provides further evidence
that the stickleback is a unique bioindicator
species that can be invaluable in the evaluation
of antiandrogenic chemicals, EDCs that appear
to pose a signiﬁcant threat of adverse effects to
both wildlife and humans.
In the test we describe here, antiandrogenic
activity is detected by comparing the kidney
content of spiggin in female sticklebacks simul-
taneously exposed to a model androgen
(17α-MT or DHT) and known antiandro-
gens, to female sticklebacks exposed solely to
the model androgen. This bioassay represents
the adaptation of the established stickleback
androgen bioassay in which the androgen spe-
cific biomarker spiggin is measured using an
ELISA (Katsiadaki et al. 2002a).
Male sticklebacks can also be used for the
in vivo detection of antiandrogenic activity;
female sticklebacks, however, provide more
consistent results because of the absence of
endogenous androgens. The bioassay can use
male sticklebacks only under extremely con-
trolled photoperiodic conditions before and
during the experiment. The reproductive status
must be fully synchronized to allow compari-
son between groups. Social hierarchies within
tanks can preclude any conclusions, as domi-
nant males can suppress the onset of breeding
in repressed males in the control groups. In
addition, the endogenous levels of androgens
in the dominant males are extremely high
(Mayer et al. 1990), thereby masking the
antiandrogenic effect of the test compounds.
The development of strict protocols to ensure
that the ﬁne balance between environment and
reproductive status of male ﬁsh is achieved is
certainly one area of further work that would
be highly beneﬁcial. In general, it appears to be
easier to manipulate the reproductive status of
male fish during the autumn and winter
months when the levels of endogenous andro-
gens and AR numbers are low.
At 5 µg/L, 17α-MT effectively over-
whelmed the antiandrogenic activity of the test
compounds at the concentration they were
administered. Using this information we modi-
fied the experimental design for the second
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Figure 4. Amounts of spiggin per gram of body weight (± SE) in female stickle-
backs (control and 17α-MT–treated with simultaneous exposure to ﬂutamide
(FL), vinclozolin (VZ), and linuron (LN).
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Figure 5. Amounts of spiggin per gram of body weight (± SE) in female stickle-
backs (control and 17α-MT–treated with simultaneous exposure to ﬂutamide
(FL), vinclozolin (VZ), fenitrothion (FN), and linuron (LN). 
Treatments shown with the same letter do not differ signiﬁcantly from each other (p< 0.05).exposure experiment, during which 17α-MT
was applied at a concentration of 0.5 µg/L. We
believed that this concentration would be sufﬁ-
cient to induce spiggin production but would
not be so high as to mask any antiandrogenic
activity.
In the second semistatic exposure, the
average spiggin content in the androgen-
exposed females was approximately one-third
of that for the ﬁrst exposure experiment. FL,
VZ, and LN significantly antagonized
17α-MT–induced spiggin production in the
female stickleback (Figure 5). The additional
antiandrogen FN proved to be exceptionally
potent in vivo. At its lowest administered con-
centration, only 15 µg/L, its antiandrogenic
activity was analogous to the activity of the
pharmaceutical antiandrogen FL at 250 µg/L.
Furthermore, at the highest administered con-
centration, 150 µg/L, FN completely inhib-
ited spiggin production. The spiggin content
at this concentration is statistically the same as
that obtained for the water and solvent control
groups. These results provide the ﬁrst in vivo
evidence of antiandrogenic activity for both
LN and FN in teleosts.
When the administration of test com-
pounds is waterborne, one should consider the
differences in solubility, stability, and means
of transport to target tissues that exist between
the test compounds and that influence the
magnitude of biological response. In this case
the differences between the two androgens
(17α-MT and DHT) could have more than
one cause. Our own unpublished data suggest
that 17α-MT induces higher kidney hyper-
trophy than DHT when used at the same con-
centration in both ﬂow-through and semistatic
exposure systems. Furthermore, measurement
of the model androgens in the aquaria water
under semistatic conditions suggests that
17α-MT is far more stable than DHT.
Unfortunately, the number of studies on
antiandrogens in ﬁsh is limited, and as far as
the authors are concerned, this current study
is only the third time that FL, a classic mam-
malian antiandrogen, has been shown to be
antiandrogenic in teleosts.
Sower et al. (1983) showed that adminis-
tration of FL along with 17α-MT to juvenile
steelhead trout (incorporated in food pellets)
prevented epidermal thickening and reduced
growth rate, characteristics that were both
caused by 17α-MT alone.
Wells and Van Der Kraak (2000) provided
the first evidence that certain environmental
chemicals bind to AR in ﬁsh but exhibit inter-
species and tissue differences in their binding
proﬁle. The lack of AR binding of some classic
antiandrogens such as FL and VZ (and its
metabolites M1 and M2) in rainbow trout,
goldﬁsh, and fathead minnow must be consid-
ered, especially when these species are used as
models for endocrine research purposes.
The induction of nuptial tubercles in
female fathead minnows has been proposed as
a biomarker of androgen exposure. The con-
centrations of 17α-MT used to induce the for-
mation of these tubercles range from 200 to
2,000 µg/L (Ankley et al. 2001; Smith 1974),
which is 400–4,000 times the amount required
to induce spiggin production in female stickle-
backs. Furthermore, administration of 17α-
MT at high concentrations resulted in high
mortalities in the study conducted by Ankley
et al. (2001). The antiandrogenic activity of FL
has been detected in male fathead minnows
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Figure 6. Amounts of spiggin per gram of body
weight (± SE) in male and female sticklebacks
treated with DHT alone or in combination with ﬂu-
tamide. EE2 was used as a negative control. 
*Significant (p < 0.05) inhibition of DHT-induced spiggin
induction by ﬂutamide.
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Figure 7. Inhibition of DHT-induced spiggin produc-
tion by flutamide in a dose–response manner. All
groups except controls received 5 µg/L of DHT.
Treatments shown with the same letter do not differ signiﬁ-
cantly from each other (p < 0.05). 
Table 1. Analytical veriﬁcation of test compounds in water (relevant to Figures 5 and 7).
Nominal Determined concentration (µg/L)
Compound concentration (µg/L) D3ba D3ab D10b D10a D17b D17a
Linuron (R1c) 150 91 116 63 167 107 111
Linuron (R2d) 150 91 94 61 177 94 101
Linuron (R1) 15 5.4 6.1 3.4 11 5.9 8.5
Linuron (R2) 15 5.9 6.3 3.9 12 6.6 8.2
Control (R1) 0 < 0.5 < 0.5 < 0.5 < 0.5 < 0.5 < 0.5
Control (R2) 0 < 0.5 < 0.5 < 0.5 < 0.5 < 0.5 < 0.5
Flutamide (R1) 250 231 243 176 251 195 212
Flutamide (R2) 250 232 248 178 256 191 210
Flutamide (R1) 25 17 18 13 18 16 18
Flutamide (R2) 25 18 17 11 18 13 15
Control (R1) 0 < 0.5 < 0.5 < 0.5 < 0.5 < 0.5 < 0.5
Control (R2) 0 < 0.5 < 0.5 < 0.5 < 0.5 < 0.5 < 0.5
Vinclozolin (R1) 250 3.5 177 3.8 127 1.9 178
Vinclozolin (R2) 250 3.5 210 4.5 92 2.7 103
Vinclozolin (R1) 25 < 0.5 11 < 0.5 8.8 < 0.5 10
Vinclozolin (R2) 25 < 0.5 7 < 0.5 7.3 < 0.5 7.2
Control (R1) 0 < 0.5 < 0.5 < 0.5 < 0.5 < 0.5 < 0.5
Control (R2) 0 < 0.5 < 0.5 < 0.5 < 0.5 < 0.5 < 0.5
Fenitrothion (R1) 150 119 141 127 133 129 135
Fenitrothion (R2) 150 137 140 134 137 124 131
Fenitrothion (R1) 15 12 13 11 12 9 10
Fenitrothion (R2) 15 8.5 10 12 13 11 12
Control (R1) 0 < 0.5 < 0.5 < 0.5 < 0.5 < 0.5 < 0.5
Control (R2) 0 < 0.5 < 0.5 < 0.5 < 0.5 < 0.5 < 0.5
17α-MT (R1) 0.5 0.04 0.45 0.03 0.46 0.02 0.47
17α-MT (R2) 0.5 0.03 0.46 0.02 0.49 0.03 0.48
Control (R1) 0 < 0.01 < 0.01 < 0.01 < 0.01 < 0.01 < 0.01
Control (R2) 0 < 0.01 < 0.01 < 0.01 < 0.01 < 0.01 < 0.01
Nominal Determined concentration (µg/L)
Compound concentration (µg/L) W1ae W1bf W2a W2b W3a W3b
FL (ﬂow-through) 500 396 394 361 335 380 392
FL (ﬂow-through) 250 205 194 202 205 200 201
FL (ﬂow-through) 125 99 114 104 96 101 103
FL (ﬂow-through) 50 40 40 39 49 41 42
FL (ﬂow-through) 10 6.7 8.1 8.5 8.2 7.5 7.9
FL (ﬂow-through) 1 < 0.1 3.3 3.2 3.3 2.1 2
FL (ﬂow-through) 0 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1
Control (FL) 0 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1
DHT (ﬂow-through)g 5 4.99 4.92 4.95 4.93 4.96 4.95
Control (DHT) 0 0 0 0 0 0 0
Abbreviations: D, day; R, replicate; W, week. aDay 3 before addition of fresh solution in the semistatic system. bDay 3 after
addition in the semistatic system. cTank replicate 1. dTank replicate 2. eWeek 1 ﬁrst sample. fWeek 1 second sample. gThe
recovered concentrations of DHT from the tanks were very similar and close to the nominal concentration; thus we report
only average values from all tanks on each sampling occasion. Katsiadaki et al.
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through a reduction in the number of nuptial
tubercles (Panter et al. 2004). However, a FL
concentration of 1,000 µg/L (4 times greater
than that used in this study) was required to
elicit this response. In addition, exposure of fat-
head minnow embryos to VZ at concentrations
ranging from 90 to 1,200 µg/L did not result in
any adverse effects on sexual differentiation or
reproductive health (Makynen et al. 2000).
These ﬁndings draw into question the suitabil-
ity of fathead minnow bioassays for the detec-
tion of EDCs with antiandrogenic activity.
More recently, Bayley et al. (2002)
exposed juvenile guppies to FL, VZ, and
p,p´-DDE via the food from birth to adult-
hood and concluded that all three chemicals
had a clear demasculinizing effect (reduction
of orange display coloration, gonopodium
development, reduction in sperm count, and
suppressed courtship behavior). However,
the length of the study and the nonwater-
borne exposure preclude any comparisons of
the sensitivity of the bioassay with the stickle-
back assay.
In addition, Kinnberg and Toft (2003)
exposed sexually mature male guppies to a
number of estrogenic and antiandrogenic
compounds. Although FL, p,p´ DDE, and
estrogens blocked spermatogonial mitosis, VZ
did not have any adverse effects.
The in vivo studies that failed to demon-
strate androgen antagonism by mammalian
and environmental antiandrogens in teleosts
suggest profound differences in the AR bind-
ing speciﬁcities between species.
In the stickleback kidney, previous studies
have shown that no specific binding of
11-ketotestosterone (11-KT) or testosterone
was detected in either cytosolic or nuclear frac-
tions, although displacement of tritiated
11-KT with unlabeled 11-KT was observed in
the kidney membrane fraction (Jakobsson
et al. 1996). More recently, molecular cloning
of a nuclear AR in the stickleback kidney has
revealed that it is the classic mammalian type,
AR2 or AR beta (GenBank accession no.
AAO83572/3; http://ncbi.nlm.nih.gov/
Genbank), as we have previously speculated
on the basis of androgen potency (Katsiadaki
et al. 2002a). The presence of a nuclear AR
homologous to the mammalian AR in the
stickleback kidney has important implications
regarding the use of the species as a model
organism for EDC research.
The most promising mammalian assay for
androgens and antiandrogens is the castrated
male rat assay, widely known as the Hershberger
assay (Ashby and Lefevre 2000; Stocker et al.
2000). However, the prerequisite for surgical
castration of rats makes it a rather laborious
test for chemical screening. The need for a
more rapid test for antiandrogens is reﬂected
by the increasing number of alternative tests
such as the weanling male rat assay (Ashby and
Lefevre 1997), the intact young male rat assay
(O’Connor et al. 1999), the peripubertal intact
male assay (Stocker et al. 2000), the use of
androgen-stimulated immature intact male rats
(Ashby et al. 2002), in utero exposure (Shultz
et al. 2001), and the use of gonadotrophin
release hormone–inhibited rats (Nellemann
et al. 2003).
Although surgical castration is not required
in these alternative tests, the majority of these
assays rely on the same principle changes in the
reproductive or accessory sex gland weights
upon treatment. This end point has received
criticism because chemical treatment may
affect growth rate; thus the relationship
between body weight and/or accessory gland
weight is problematic (Marty et al. 2003).
It should be added that although in utero
and in vivo exposure (You et al. 1998) of
weaning rats to p,p´-DDE confirmed the
antiandrogenic activity observed in vitro by
Kelce et al. (1995), exposure of adult male
rodents has failed to identify any antiandro-
genic effects (Leavens et al. 2002). With the
adaptation of the spiggin assay described here,
a dramatic inhibition of photoperiodically or
androgen-induced kidney hypertrophy is
detectable in intact adult sticklebacks within
21 days of exposure, which highlights the
advantages that the assay presents. The expo-
sure period of 21 days was chosen because it is
used as the standard period in the ﬁsh screen-
ing assay for the detection of endocrine-active
substances (Organisation for Economic Co-
operation and Development 2004). In our
experience, a 3-week exposure period is sufﬁ-
cient for detecting changes in biomarkers (i.e.,
spiggin and VTG).
EE2 was used in one exposure as a negative
control (Figure 6). As expected, EE2 at a con-
centration that is effective at inducing VTG
production in a wide range of fish did not
induce spiggin in females. Indeed, there is a
suggestion that it inhibited/reduced spiggin
production in males. Both ﬁndings are in line
with previous observations by Oguro (1957),
who ﬁrst reported that estrogens do not stimu-
late kidney hypertrophy in the stickleback but
do result in regression of kidney hypertrophy.
Exposure to high concentrations of estradiol
also results in lower spiggin levels in male ﬁsh
(unpublished data). We are currently testing a
number of estrogens in androgen-treated
female ﬁsh to determine whether they display
the same antiandrogenic effect as in the males.
It is as yet unclear whether the antiandro-
genic effect of estrogens is exerted through
their binding to the AR in a genomic way
(Kelce and Wilson 1997; Sohoni and Sumpter
1998); in a nongenomic way, mediated by an
estrogen membrane receptor (Loomis and
Thomas 2000); or via other mechanism(s)
involving feedback control of sex steroid levels
to gonadotrophins (Shultz et al. 2001).
One of the great advantages of the
stickleback as a model organism is that the
simultaneous assessment of an androgen and
estrogen end point (we have also developed a
homologous ELISA for stickleback VTG) can
provide vital clues regarding the mechanisms
responsible for endocrine adverse effects. We
applied the VTG ELISA to detect estrogenicity
of the test compounds and found that none of
the tested environmental antiandrogens
induced VTG in male fish or increased the
VTG content in female fish (results not
shown). As the two protein markers are pro-
duced and stored in different organs (kidney
for spiggin, plasma or liver for VTG), a single
ﬁsh can be analyzed for androgenic and estro-
genic activity. This versatility reduces the num-
ber of test organisms needed, which is of great
importance both ethically and economically.
There are several other reasons why the
stickleback is an ideal European bioindicator
species, as discussed elsewhere (Katsiadaki
et al. 2002b). 
Conclusions
The stickleback androgen bioassay can be
adapted to detect antiandrogens in two ways:
• Simultaneous treatment of females with an
androgen
• Photoperiodic manipulation of male stickle-
back reproductive status
The degree of antagonism by a given
compound depends on the following:
• Type and concentration of model androgen
used (17α-MT being more potent than
DHT).
•Stability/solubility of the androgen/
antiandrogen in water (particularly when
semistatic exposure is employed).
• Reproductive status of fish/experimental
conditions (competition with natural ligands
in male ﬁsh).
• On the basis of the results of the present
study, we propose the use of DHT at 5 µg/L
for flow-through systems and 17α-MT at
0.5 µg/L for either flow-through or semi-
static exposures in order to stimulate spiggin
production in female ﬁsh.
• This work represents the ﬁrst study in teleosts
to demonstrate that linuron is an androgen
antagonist.
• Fenitrothion is an exceptionally potent andro-
gen antagonist in vivo (also first evidence
in teleosts).
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